359 Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

On Nov 16, 2020
@nathanbenaich shared
For those so inclined, here's a link to the abstract: https://t.co/BcA5ncTVy6 "Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial"
Open

Neustadt, Austria 10Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria 11Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria 12Division of Nuclear Medicine, Department of Biomedical Imaging ...

ash.confex.com
On Nov 16, 2020
@nathanbenaich shared
For those so inclined, here's a link to the abstract: https://t.co/BcA5ncTVy6 "Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial"
Open

359 Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

359 Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Neustadt, Austria 10Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria 11Department of Otorhinolaryngology, Head and Neck Surgery, Medical ...